Market Overview

Affymax Shares Fall Amid Plan to Halt Expansion of Pilot, Pare Loss as Analysts Defend

Share:

Shares of Affymax (NASDAQ: AFFY) gapped more than 30 percent lower at Thursday morning's open following an 8-K which disclosed the company will halt the expansion of its Omontys pilot. The company suggested continuing use of Omontys for the management of anemia.

The stock began bouncing shortly after the open as traders began passing around research notes which suggested the news is not as bad as feared.

Affymax shares are now down around 6 percent heading into the last few hours of trade. The stock last traded around $15.60.

In addition to being defended at Stifel Nicolaus and Baird, a Piper Jaffray analyst argued Affymax shares could move into the mid-$20 range by the end of April if a deal for Omontys with Fresenius Medical is agreed upon. Related to the concern of allergic reactions, the Piper analyst noted these reactions were "very small" and should not be concerning to doctors. The analyst believes many doctors prefer Omontys and said "they want to keep their patients on it."

Stifel, Baird and Piper Jaffray maintain their equivalent of a Buy rating on shares of Affymax.

Latest Ratings for AFFY

DateFirmActionFromTo
Mar 2013DowngradesSell
Feb 2013DowngradesBuyNeutral
Feb 2013DowngradesMarket OutperformMarket Underperform

View More Analyst Ratings for AFFY
View the Latest Analyst Ratings

Posted-In: Analyst Color News Analyst Ratings Movers

 

Related Articles (AFFY)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
POWLSidoti & Co.Maintains47.0
XDeutsche BankInitiates Coverage On121.0
WTEBMO CapitalMaintains18.0
DOLBMO CapitalMaintains50.0
NABMO CapitalMaintains69.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Mid-Day Market Update: Markets Regaining Losses, Ulta Salon Drops After CEO Leaves

Weight Watchers Posts Strong Fourth Quarter, Drops on Earnings Guidance